Transcripts - Participants -Matt Gline, CEO -Mayukh, Sukhatme, President & CIO -Frank Torti, Chair Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to … Continue Reading
Read nowTranscripts - Participants Matt Kapusta, Chief Executive Officer Ricardo Dolmetsch, President of R&D Sara Tabrizi, KOL Maria Cantor, Chief Corporate Affairs Officer Maria Cantor, Chief Corporate Affairs Officer Good morning, … Continue Reading
Read nowResearch - Video Summary: Gossamer Bio (GOSS) will be reporting open label extension data in the coming weeks which could demonstrate that their inhaled seralutinib is a … Continue Reading
Read nowTranscripts - Participants Richard Aranda, CMO Fahim Hasnain, CEO Bryan Giruado, CFO Fahim Hasnain, CEO We’re very excited about getting our phase three off the ground. We’re … Continue Reading
Read nowTranscripts - Participants Antony Mattessich, Chief Executive Officer Arshad Khanani, KOL Peter Kaiser Chief Advisor for Retina Rabia Ozden, Chief Medical Officer Donald Notman, Chief Financial Officer Chris White, … Continue Reading
Read nowInsights - Day One (DAWN) announced a $150M raise priced at $13/share after presenting additional data at ASCO 2023. Importantly, the company formed a regulatory pathway in … Continue Reading
PremiumTranscripts - Participants August Moretti, Chief Financial Officer David Kirn, Chief Executive Officer Jennifer Taylor-Cousar, Lead Investigator of 4D-710 Ladies and gentlemen, thank you for standing by, … Continue Reading
Read now
